Lung Cancers Completed Phase 1 Trials for Gemcitabine (DB00441)

Also known as: LUng Cancer / Cancer, Lung / Lung neoplasm malignant / Lung cancer NOS / Cancer of lung / Ca lung

IndicationStatusPhase
DBCOND0072929 (Lung Cancers)Completed1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00620295Bortezomib and Gemcitabine in Treating Older Patients With Advanced Solid TumorsTreatment
NCT00343408AZD2171 and Standard Combination Chemotherapy in Treating Patients With Advanced Non-Small Cell Lung Cancer or Colorectal CancerTreatment
NCT00016315Gemcitabine, Carboplatin or Paclitaxel Plus Radiation Therapy in Treating Patients With Stage IIIA or IIIB Non-Small Cell Lung CancerTreatment
NCT00014456Combination Chemotherapy Plus Filgrastim in Treating Patients With Advanced Solid TumorsTreatment
NCT00019513Combination Chemotherapy in Treating Patients With Recurrent, Refractory, or Metastatic Solid Tumors or LymphomasTreatment
NCT00004095Irinotecan Plus Gemcitabine in Treating Patients With Unresectable or Metastatic Solid TumorsTreatment